Literature DB >> 18543041

11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.

Y Yamamoto1, Y Nishiyama, N Kimura, R Kameyama, N Kawai, T Hatakeyama, M Kaji, M Ohkawa.   

Abstract

PURPOSE: The aim of the study is to retrospectively investigate the usefulness of 11C-acetate (ACE)-positron emission tomography (PET) for evaluation of brain glioma, in comparison with 11C-methionine (MET) and 2-deoxy-2-18F-fluoro-D-glucose (FDG). PROCEDURES: Fifteen patients with brain glioma referred to initial diagnosis were examined with ACE, MET, and FDG-PET. Five patients had low-grade gliomas (grade II), three had anaplastic astrocytomas (grade III), and seven had glioblastomas (grade IV). PET results were evaluated by visual and semiquantitative analysis. For semiquantitative analysis, the standardized uptake value (SUV) and tumor to contralateral normal gray matter (T/N) ratio were calculated. The sensitivity for detection of high-grade gliomas was calculated using visual analysis.
RESULTS: Sensitivities of ACE, MET, and FDG were 90%, 100%, and 40%, respectively. ACE and MET T/N ratios were significantly higher than that of FDG. ACE and FDG SUV in high-grade gliomas were significantly higher than that in low-grade gliomas. No significant differences were observed using MET.
CONCLUSIONS: ACE PET is a potentially useful radiotracer for detecting brain gliomas and differentiating high-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543041     DOI: 10.1007/s11307-008-0152-5

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  27 in total

Review 1.  PET imaging of prostate cancer with 11C-acetate.

Authors:  Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

2.  11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.

Authors:  Dominique Delbeke; C Wright Pinson
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

3.  Clinical PET in oncology: not only FDG.

Authors:  Cristina Nanni; Domenico Rubello; Adil Al-Nahhas; Stefano Fanti
Journal:  Nucl Med Commun       Date:  2006-09       Impact factor: 1.690

4.  Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.

Authors:  W Weber; P Bartenstein; M W Gross; D Kinzel; H Daschner; H J Feldmann; G Reidel; S I Ziegler; C Lumenta; M Molls; M Schwaiger
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

Review 5.  Clinical application of PET for the evaluation of brain tumors.

Authors:  R E Coleman; J M Hoffman; M W Hanson; H D Sostman; S C Schold
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

6.  PET imaging of brain astrocytoma with 1-11C-acetate.

Authors:  Ren-Shyan Liu; Cheng-Pei Chang; Lee-Shing Chu; Yum-Kung Chu; Hung-Jen Hsieh; Chi-Wei Chang; Bang-Hung Yang; Shan-Hui Yen; Min-Chao Huang; Su-Quin Liao; Shin-Hwa Yeh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-11       Impact factor: 9.236

7.  Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.

Authors:  Kenji Torii; Naohiro Tsuyuguchi; Joji Kawabe; Ichiro Sunada; Mitsuhiro Hara; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2005-12       Impact factor: 2.668

8.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Authors:  Sungeun Kim; June-Key Chung; So-Hyang Im; Jae Min Jeong; Dong Soo Lee; Dong Gyu Kim; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

9.  Increased amounts of D-enantiomer dependent on alkaline concentration in the synthesis of L-[methyl-11C]methionine.

Authors:  K Ishiwata; T Ido; W Vaalburg
Journal:  Int J Rad Appl Instrum A       Date:  1988

10.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

View more
  25 in total

Review 1.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

2.  The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma.

Authors:  Soyoung Kim; Dongwoo Kim; Se Hoon Kim; Mi-Ae Park; Jong Hee Chang; Mijin Yun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-06       Impact factor: 9.236

3.  99mTc-tetrofosmin SPECT for glioma evaluation.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Spyridon Voulgaris; Konstantinos S Polyzoidis; Andreas D Fotopoulos
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488

4.  Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.

Authors:  Yoshiro Kawase; Yuka Yamamoto; Reiko Kameyama; Nobuyuki Kawai; Nobuyuki Kudomi; Yoshihiro Nishiyama
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

5.  Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.

Authors:  Osamu Manabe; Naoya Hattori; Shigeru Yamaguchi; Kenji Hirata; Kentaro Kobayashi; Shunsuke Terasaka; Hiroyuki Kobayashi; Hiroaki Motegi; Tohru Shiga; Keiichi Magota; Noriko Oyama-Manabe; Ken-ichi Nishijima; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

Review 6.  Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.

Authors:  Anna Falk Delgado; Alberto Falk Delgado
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

Review 7.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

Review 8.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

Review 9.  Imaging biomarkers in primary brain tumours.

Authors:  Egesta Lopci; Ciro Franzese; Marco Grimaldi; Paolo Andrea Zucali; Pierina Navarria; Matteo Simonelli; Lorenzo Bello; Marta Scorsetti; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-18       Impact factor: 9.236

Review 10.  Attacking the supply wagons to starve cancer cells to death.

Authors:  Elizabeth M Selwan; Brendan T Finicle; Seong M Kim; Aimee L Edinger
Journal:  FEBS Lett       Date:  2016-03-22       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.